Table of Contents

company-logo

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.

Oramed Pharmaceuticals Dividend Announcement

• Oramed Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Oramed Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Oramed Pharmaceuticals Dividend History

Oramed Pharmaceuticals Dividend Yield

Oramed Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Oramed Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Oramed Pharmaceuticals Financial Ratios

P/E ratio-21.52
PEG ratio1.51
P/B ratio0.64
ROE-2.94%
Payout ratio0.00%
Current ratio2.25
Quick ratio2.25
Cash Ratio0.07

Oramed Pharmaceuticals Dividend FAQ

Does Oramed Pharmaceuticals stock pay dividends?
Oramed Pharmaceuticals does not currently pay dividends to its shareholders.
Has Oramed Pharmaceuticals ever paid a dividend?
No, Oramed Pharmaceuticals has no a history of paying dividends to its shareholders. Oramed Pharmaceuticals is not known for its dividend payments.
Why doesn't Oramed Pharmaceuticals pay dividends?
There are several potential reasons why Oramed Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Oramed Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Oramed Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Oramed Pharmaceuticals a dividend aristocrat?
Oramed Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Oramed Pharmaceuticals a dividend king?
Oramed Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Oramed Pharmaceuticals a dividend stock?
No, Oramed Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Oramed Pharmaceuticals stocks?
To buy Oramed Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Oramed Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.